Literature DB >> 16279255

Covariate-based constrained randomization of group-randomized trials.

Lawrence H Moulton1.   

Abstract

Group-randomized study designs are useful when individually randomized designs are either not possible, or will not be able to estimate the parameters of interest. Blocked and/or stratified (for example, pair-matched) designs have been used, and their properties statistically evaluated by many researchers. Group-randomized trials often have small numbers of experimental units, and strong, geographically induced between-unit correlation, which increase the chance of obtaining a "bad" randomization outcome. This article describes a procedure--random selection from a list of acceptable allocations--to allocate treatment conditions in a way that ensures balance on relevant covariates. Numerous individual- and group-level covariates can be balanced using exact or caliper criteria. Simulation results indicate that this method has good frequency properties, but some care may be needed not to overly constrain the randomization. There is a trade-off between achieving good balance through a highly constrained design, and jeopardizing the appearance of impartiality of the investigator and potentially departing from the nominal Type I error.

Entities:  

Mesh:

Year:  2004        PMID: 16279255     DOI: 10.1191/1740774504cn024oa

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  86 in total

Review 1.  Review of Recent Methodological Developments in Group-Randomized Trials: Part 1-Design.

Authors:  Elizabeth L Turner; Fan Li; John A Gallis; Melanie Prague; David M Murray
Journal:  Am J Public Health       Date:  2017-04-20       Impact factor: 9.308

2.  Controlled trial of active tuberculosis case finding in a Brazilian favela.

Authors:  A C Miller; J E Golub; S C Cavalcante; B Durovni; L H Moulton; Z Fonseca; D Arduini; R E Chaisson; E C C Soares
Journal:  Int J Tuberc Lung Dis       Date:  2010-06       Impact factor: 2.373

3.  N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial.

Authors:  Lewis J Radonovich; Michael S Simberkoff; Mary T Bessesen; Alexandria C Brown; Derek A T Cummings; Charlotte A Gaydos; Jenna G Los; Amanda E Krosche; Cynthia L Gibert; Geoffrey J Gorse; Ann-Christine Nyquist; Nicholas G Reich; Maria C Rodriguez-Barradas; Connie Savor Price; Trish M Perl
Journal:  JAMA       Date:  2019-09-03       Impact factor: 56.272

Review 4.  Cluster-Randomized Studies.

Authors:  Eva Lorenz; Sascha Köpke; Holger Pfaff; Maria Blettner
Journal:  Dtsch Arztebl Int       Date:  2018-03-09       Impact factor: 5.594

5.  An evaluation of constrained randomization for the design and analysis of group-randomized trials with binary outcomes.

Authors:  Fan Li; Elizabeth L Turner; Patrick J Heagerty; David M Murray; William M Vollmer; Elizabeth R DeLong
Journal:  Stat Med       Date:  2017-08-07       Impact factor: 2.373

6.  Observational Study on a Mindfulness Training for Smokers within a Smoking Cessation Program.

Authors:  James M Davis; Simon B Goldberg; Kelly S Angel; Rachel H Silver; Emily A Kragel; Delaney J Lagrew
Journal:  Mindfulness (N Y)       Date:  2017-06-20

7.  swpermute: Permutation tests for Stepped-Wedge Cluster-Randomised Trials.

Authors:  Jennifer Thompson; Calum Davey; Richard Hayes; James Hargreaves; Katherine Fielding
Journal:  Stata J       Date:  2019-12-18       Impact factor: 2.637

8.  Rerandomization to Balance Tiers of Covariates.

Authors:  Kari Lock Morgan; Donald B Rubin
Journal:  J Am Stat Assoc       Date:  2016-01-15       Impact factor: 5.033

9.  An evaluation of constrained randomization for the design and analysis of group-randomized trials.

Authors:  Fan Li; Yuliya Lokhnygina; David M Murray; Patrick J Heagerty; Elizabeth R DeLong
Journal:  Stat Med       Date:  2015-11-23       Impact factor: 2.373

10.  Optimized probability sampling of study sites to improve generalizability in a multisite intervention trial.

Authors:  Jennifer L Kraschnewski; Thomas C Keyserling; Shrikant I Bangdiwala; Ziya Gizlice; Beverly A Garcia; Larry F Johnston; Alison Gustafson; Lindsay Petrovic; Russell E Glasgow; Carmen D Samuel-Hodge
Journal:  Prev Chronic Dis       Date:  2009-12-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.